# A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-study-of-epigenetic-therapy-with-hydralazine-and-magnesium-valproate/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Myrna Candelaria,Dolores Gallardo‐Rincón,Claudia Arce,Lucely Cetina,José Luis Aguilar-Ponce,Óscar Arrieta,Aurora González‐Fierro,Alma Chávez‐Blanco,Erik de la Cruz-Hernandez,Maria Fernanda Vieira Cunha Camargo,Catalina Trejo‐Becerril,Enrique Pérez‐Cárdenas,Carlos Pérez‐Plasencia,Lucía Taja‐Chayeb,Talía Wegman-Ostrosky,Alma Luísa Revilla Vázquez,Alfonso Dueñas‐González |
| Citations | 253 |
| DOI | 10.1093/annonc/mdm204 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2081159709 |
| PMID | 17761710 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Lucely Cetina](https://scholariq.org/researchers/lucely-cetina/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Paper topics

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.